CDK5 and bone cancer: Cdk5 inhibition attenuated mechanical allodynia and thermal hyperalgesia through suppressing mGluRs and (or) NMDAR phosphorylation in both bone cancer pain (Zhang R. et al., 2012) and post-operative pain (Liu et al., 2014) models.